Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • Invest with CPF/SRS
    • Singapore Stocks
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

3SBIO

35.900
+0.9202.63%
Volume:35.89M
Turnover:1.27B
Market Cap:87.31B
PE:38.02
High:36.100
Open:34.480
Low:33.600
Close:34.980
52wk High:36.100
52wk Low:5.426
Shares:2.43B
HK Float Shares:2.43B
Volume Ratio:0.56
T/O Rate:1.48%
Dividend:0.25
Dividend Rate:0.70%
EPS(LYR):0.944
ROE:13.95%
ROA:6.19%
PB:4.89
PE(LYR):38.02
PS:8.79

Loading ...

OverviewCompanyNewsFilings

Concept

Hillhouse Capital Related+0.14%
Aesthetic Medicine+1.37%

Capital Flow

 
Inflow:
 
Outflow:
 
 
 
 
 
 
 
 
 
 
 
 
 
 

News

BioNTech, Bristol Myers Say Read-Out Confirms Dose Selection for the Ongoing Pivotal Phase Iii Rosetta Lung-01 Trial

THOMSON REUTERS
·
Yesterday

BioNTech, Bristol Myers Squibb Say Bnt327 Plus Chemotherapy Shows Encouraging Antitumor Activity in Patients With Extensive-Stage Small Cell Lung Cancer

THOMSON REUTERS
·
Yesterday

BioNTech, Bristol Myers Say Interim Phase Ii Data Showed a 76.3% Confirmed Objective Response Rate, 100% Disease Control Rate

THOMSON REUTERS
·
Yesterday

China Merchants International: Chinese Pharmaceutical Stocks Expected to Continue Rising on Innovation Drug Overseas Expansion and Domestic Policy Optimization, Recommends Buying 3SBIO (01530) and Others

Stock News
·
Yesterday

Analyst Rate

Buy
Buy
93.33%
Hold
6.67%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 29, 2025
Ex-dividend Date
Jul 21, 2025 Dividend Per Share 0.25 HKD
Financial Report Announcement
Mar 25, 2025 Post Market
Financial Report Announcement
Aug 22, 2024 Post Market
Ex-dividend Date
Jul 22, 2024 Dividend Per Share 0.25 HKD

Dividend History

Ex-DateDividend
2018-06-290.0685
2022-06-270.2
2023-06-270.1
2024-07-220.25
2025-07-210.25

Valuation Analysis

32.46
Current
11.71
Sector Average
98.95%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
32.46
Maximum
35.16
+1 STD
17.45
Minimum
5.67
-1 STD
5.96
Average
11.71

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.